Search results
Study uncovers at least one cause of roadblocks to cancer immunotherapy
Medical Xpress· 12 hours agoT cells—the body's foot soldiers against invaders, ranging from everyday infections to cancers—are...
Researchers find B cells drive responses of other immune cells, can be modified to prevent multiple...
Medical Xpress· 15 hours agoIn individuals with multiple sclerosis (MS), abnormally active respiration in B cells drives pro-inflammatory responses of myeloid cells and T cells, leading them to attack the protective sheath ...
Newly discovered mechanism of T-cell control can interfere with cancer immunotherapies
Science Daily· 4 days agoThe T cells of the immune system are the main players in the defense against viral infections and tumor cells. The body must therefore keep a tight control on T cell ...
Revolutionizing Cancer Treatment: Key to Prolonging CAR T Cell Life Uncovered
SciTechDaily· 7 days agoFOXO1 is required for T cell memory and is linked to longer-lasting clinical outcomes in CAR T cell...
TC BioPharm Announces Exercise of Warrants for £3.1 Million Gross Proceeds
Morningstar· 11 hours agoTC BioPharm (Holdings) plc ("TC BioPharm" or the "Company") (NASDAQ: TCBP), a clinical stage biotechnology company developing platform allogeneic gamma-delta T cell ...
New technique improves T cell-based immunotherapies for solid tumors
Medical Xpress· 5 days agoScientists from Scripps Research have enhanced an existing immunotherapy by removing the sugar coating surrounding solid tumors—such as in melanoma, breast, and prostate cancer—so T cells can ...
Replay wins IND clearance for PRAME T cell cancer therapy
Clinical Trials Arena via Yahoo Finance· 6 days agoGenome writing company Replay Bio has had its investigational new drug (IND) application cleared by...
Why Is TC Biopharm (TCBP) Stock Up 51% Today?
InvestorPlace· 14 hours agoTC BioPharm (NASDAQ:TCBP) stock is rocketing higher on Monday after the clinical-stage biopharmaceutical company announced a major deal to acquire...
Targeting myeloma essential genes using NOT Gated CAR T-cells, a computational approach - Leukemia
Nature· 7 days agoChimeric antigen receptor (CAR) T-cells have recently been demonstrated to be highly effective in the disease, but the survival curves are yet to plateau. Thus, on-target, off-tumour toxicity ...
Vyriad Announces Oral Presentation at the 27th American Society of Gene & Cell Therapy Annual...
KTLA-TV Los Angeles· 8 hours agoVyriad, Inc., a clinical-stage biotechnology company developing the next generation of targeted genetic therapies, today announced that its abstract, In Vivo Generation of αCD19-CAR T Cells ...